NCT02934555View on ClinicalTrials.gov

Ubiquinol as a Metabolic Resuscitator in Post-Cardiac Arrest

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

May 25, 2019

Study Completion Date

June 2, 2019

Conditions
Cardiac Arrest
Interventions
DRUG

Ubiquinol

300 mg Ubiquinol (3 mL liquid Ubiquinol).

DIETARY_SUPPLEMENT

Ensure

50 mL Ensure

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

Kaneka Medical America LLC

INDUSTRY

lead

Beth Israel Deaconess Medical Center

OTHER

NCT02934555 - Ubiquinol as a Metabolic Resuscitator in Post-Cardiac Arrest | Biotech Hunter | Biotech Hunter